FlexiSEQ

Ascension Healthcare is a UK-based life sciences company that develops and commercializes innovative, drug-free therapies for joint health and pain management. The company's flagship product line, FlexiSEQ, utilizes proprietary Sequessome technology, which consists of ultra-deformable phospholipid vesicles designed to penetrate the skin and lubricate joints physically. This approach provides an alternative to traditional pharmacological treatments like NSAIDs, avoiding systemic side effects while effectively reducing pain and stiffness in osteoarthritis patients. Following a corporate restructuring in 2022, the company continues to market its products globally through major retail and pharmacy partnerships. Ascension Healthcare remains focused on expanding its Sequessome platform to address various musculoskeletal and dermatological conditions.